(9R,11S,14S,16R,17R)-6,6,9-Trifluoro-11,17-Dihydroxy-17-(2-Hydroxyacetyl)-10,13,16-Trimethyl-8,11,12,14,15,16-Hexahydro-7H-Cyclopent a[a]Phenanthren-3-One

CAS: 35135-68-3

Ref. 3D-FT104102

Produktinformation

• Name: (9R,11S,14S,16R,17R)-6,6,9-Trifluoro-11,17-Dihydroxy-17-(2-Hydroxyacetyl)-10,13,16-Trimethyl-8,11,12,14,15,16-Hexahydro-7H-Cyclopent a[a]Phenanthren-3-One
• Synonyme: (11β,16α)-6,6,9-Trifluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione, (8Xi,10Xi,11Beta,13Xi,16Alpha)-6,6,9-Trifluoro-11,17,21-Trihydroxy-16-Methylpregna-1,4-Diene-3,20-Dione, 6,6,9-Trifluor-11beta,17,21-trihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dion, 6,6,9-Trifluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione, Cormetasona, Cormetasone [INN], Cormetasonum, Cormethasone, Pregna-1,4-diene-3,20-dione, 6,6,9-trifluoro-11,17,21-trihydroxy-16-methyl-, (11β,16α)-, Unii-Skf3Ncf20A, Cormetasone

Beschreibung

(9R,11S,14S,16R,17R)-6,6,9-Trifluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-8,11,12,14,15,16-hexahydro-7H-cyclopenta[a]phenanthrene 3-one is a congestive heart failure drug that belongs to the group of cardiotonic drugs. It has high resistance to elution and is used in the diagnosis of autoimmune diseases. (9R,11S) 6-(1′Hexahydrocyclohexa[b]pyrrolo[2′1′b]indolizinium bromide) is a nitrogenous compound that has been employed as a pharmaceutical preparation for the treatment of cardiac disorders. The biological properties of (9R) 11-(2′Hydroxyacetyl

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 428.44 g/mol
• Formel: C₂₂H₂₇F₃O₅
• Reinheit: Min. 95%